Skip to main content

Find Clinical Trials

Home
Conditions
Restless Legs Syndrome

Clinical trial condition

Restless Legs Syndrome

Explore clinical trials studying Restless Legs Syndrome. Study availability and eligibility vary by location and protocol.

148 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Restless Legs Syndrome trial results

Completed

Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life

NCT00539461

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Boehringer Ingelheim Investigational Site Aalen, Germany

Boehringer Ingelheim Investigational Site Aarbergen, Germany

Boehringer Ingelheim Investigational Site Adendorf, Germany

Boehringer Ingelheim Investigational Site Aham, Germany

View all 317 locations

View Trial Details

Completed

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

NCT00275457

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Univ.-Klinik für Neurologie Graz, Austria

Univ.-Klinik für Neurologie Innsbruck, Austria

AKH der Stadt Linz Linz, Austria

Confraternität Privatklinik Vienna, Austria

View all 34 locations

View Trial Details

Completed

Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome

NCT00152997

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Boehringer Ingelheim Investigational Site Akita, Akita, Japan

Boehringer Ingelheim Investigational Site Kochi, Kochi, Japan

Boehringer Ingelheim Investigational Site Kurume, Fukuoka, Japan

Boehringer Ingelheim Investigational Site Otaru,Hokkaido, Japan

View Trial Details

Completed

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

NCT00375284

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: 248.616.065 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

248.616.028 Boehringer Ingelheim Investigational Site Dothan, Alabama, United States

248.616.035 Boehringer Ingelheim Investigational Site Mesa, Arizona, United States

248.616.025 Boehringer Ingelheim Investigational Site Peoria, Arizona, United States

View all 52 locations

View Trial Details

Completed

Restless Legs Syndrome in Stroke Patients

NCT01967303

Conditions: Brain Diseases, Brain Ischemia, Cardiovascular Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Validation Study for an Unobtrusive Online Sleep Measurement System

NCT01633151

Conditions: Apnea, Dyssomnias, Mental Disorders, +13 more
Locations: Helsinki Sleep Clinic, Vitalmed Research Centre Helsinki, Finland

View Trial Details

Completed

Comprehensive Police Fatigue Management Program

NCT00246051

Conditions: Apnea, Chronobiology Disorders, Dyssomnias, +18 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Simulated Driving Study in Restless Legs Syndrome

NCT01332318

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: GSK Investigational Site Albuquerque, New Mexico, United States

View Trial Details

Completed

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

NCT01455012

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Berlin, Germany

Kassel, Germany

Marburg, Germany

München, Germany

View Trial Details

Completed

Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.

NCT00311363

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Not specified

View Trial Details